You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Daiichi Sankyo and AstraZeneca’s Enhertu delivers promising trial results

Daiichi Sankyo and AstraZeneca’s breast cancer treatment, trastuzumab deruxtecan – also known as Enhertu – has been evaluated in the DESTINY-Breast04 study.